Fluorescent Probe Assay for AdoHcy Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for monitoring the activity of S-adenosyl methionine (AdoMet)-dependent methyltransferases (MTases) lack sensitivity and are inefficient for high-throughput screening, often requiring radioisotopic labeling or multiple coupled enzymes, which leads to high rates of false positives and increased costs.
Innovation Solution
The development of methods and kits that use a mutated 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) enzyme with a fluorescent probe to quantify adenosine-containing compounds like S-adenosylhomocysteine (AdoHcy) through fluorescence polarization or resonance energy transfer (FRET) assays, allowing for real-time detection and reducing background interference.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioisotopic labeling or multiple coupled enzymes are used to monitor MTase activity, then detection sensitivity is improved, but assay complexity and cost increase
Solution Approach 1:
The patent extracts and measures the AdoHcy product directly using a fluorescent probe, eliminating the need for multiple coupled enzymes or radioisotopic labeling. The fluorescent probe specifically binds to AdoHcy, allowing direct detection without complex enzymatic cascades or radioactive materials, thus reducing assay complexity while maintaining detection sensitivity.
Solution Approach 2:
The patent replaces the mechanical/enzymatic system of multiple coupled enzymes with a fluorescent probe-based detection system. The fluorescent probe directly interacts with AdoHcy through binding, and the resulting fluorescence polarization or FRET signal provides sensitive detection without requiring enzymatic conversion steps, thereby simplifying the assay while improving measurement precision.
2Measurement precision
If multiple coupled enzymes are used to process AdoHcy into a chromophore or luminophore, then detection capability is improved, but false positive rate increases
Solution Approach 1:
The patent extracts the detection step to directly measure AdoHcy binding to the fluorescent probe, removing the intermediate enzymatic processing steps that convert AdoHcy into chromophores or luminophores. This direct binding approach eliminates sources of error introduced by multiple enzymes, thereby reducing false positives while maintaining detection capability.
Solution Approach 2:
The fluorescent probe serves as a specific intermediary that directly binds to AdoHcy with high specificity. This single-step binding interaction replaces the multi-enzyme pathway, reducing the number of potential failure points and sources of false positives while maintaining the ability to detect AdoHcy production.
3Device complexity
If conventional spectroscopic kinetic methods are used to detect AdoHcy, then assay simplicity is maintained, but detection sensitivity decreases
Solution Approach 1:
The patent employs fluorescent probes that exhibit fluorescence polarization or FRET signal changes upon binding to AdoHcy. This optical property change provides high detection sensitivity, overcoming the sensitivity limitations of conventional spectroscopic methods while maintaining relative assay simplicity through a single-step binding measurement.
Solution Approach 2:
The patent replaces conventional spectroscopic detection with fluorescent probe-based detection utilizing fluorescence polarization or FRET. This substitution provides significantly enhanced sensitivity for detecting AdoHcy while maintaining assay simplicity, as the fluorescent signal can be measured directly without complex kinetic analysis or multiple measurement steps.
4Measurement precision
If high-titer antibodies are produced for AdoHcy detection, then detection sensitivity is improved, but production cost increases
Solution Approach 1:
The patent uses fluorescent probes that can be synthesized chemically at lower cost compared to producing high-titer antibodies. These probes serve as disposable detection reagents that provide sufficient sensitivity for AdoHcy detection without requiring expensive antibody production processes, thereby reducing manufacturing costs while maintaining detection sensitivity.
Solution Approach 2:
The patent replaces the biological antibody-based detection system with a chemically synthesized fluorescent probe system. This substitution eliminates the need for expensive antibody production and purification processes while providing comparable or superior detection sensitivity through the fluorescent polarization or FRET signal generated by probe-AdoHcy binding.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods provide sensitive, cost-effective, and high-throughput capable assays for detecting AdoHcy and other adenosine-containing compounds, reducing false positives and enabling efficient screening of small molecule libraries for MTase inhibitors.
Implementation Method 1
the change in fluorescence polarization or anisotropy of the fluorescent probe can be measured as an adenosine-containing compound disrupts the complex between the mutant MTAN enzyme and the fluorescent probe
Implementation Method 2
the difference in the fluorescence resonance energy transfer (FRET) between the fluorescent probe and a second fluorophore crosslinked to a cysteine residue within the mutant MTAN enzyme can be measured
Data Source
AI summary
Methods and kits for quantifying adenosine-containing molecules within an aqueous composition. Particularly, the methods utilize a competitive fluorescence-polarization and FRET-based assays that directly measure the production of adenosine-containing compounds, particularly S-adenosylhomocysteine (AdoHcy) compounds produced by MTases. The generation of AdoHcy can be quantified by displacing a novel fluorescent probe comprising a 5-carboxytetramethylrhodamine fluorophore covalently bound to an adenosine scaffold from a catalytically inert 5′-methylthioadenosine nucleosidase (MTAN) variant. One or more of the reaction materials can be pre-loaded into wells within multi-well reaction plates as a kit, which can be used to determine the enzymatic activity of MTases or conduct drug screening for potential inhibitors in a high-throughput format. Additionally, the developed assay is applicable to S-adenosyl methionine-dependent and adenosine triphosphate-dependent enzymes by detecting adenosine and various adenosine-containing molecules including 5′-methylthioadenosine, adenosine monophosphate and adenosine diphosphate produced during the course of a chemical reaction.